Drug intelligence / Profile preview

Sollievo

Development stage
Unknown
Lead developer
Aboca
Modality
Small Molecules
Administration
Oral
01

Overview

Sollievo is a phytotherapeutic product line developed by Aboca, specifically formulated to support physiological intestinal transit and alleviate constipation. The primary active components are hydroxyanthracene derivatives, such as sennosides and aloin, sourced from Senna and Aloe. These compounds function as stimulant laxatives; upon reaching the colon, they are metabolized by microbiota into active anthrones that stimulate the myenteric plexus, increasing peristaltic contractions and promoting the secretion of water and electrolytes into the intestinal lumen. To mitigate the cramping often associated with stimulant laxatives, Sollievo includes carminative herbs like Fennel, Caraway, and Cumin, which aid in the elimination of intestinal gas. It is marketed as a natural solution for digestive regularity and is available in various forms, including tablets and herbal teas.

Brand names
SollievoSollievo BioSollievo Advanced
Other names
Sollievo Bio tavoletteSollievo Bio herbal tea

Beyond the preview

Go deeper on Sollievo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sollievo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call